2022 Agenda

Friday, Oct 21, 2022

7:45 Registration and breakfast
8:25 Opening remarks
Dr. Taymaa May and Dr. Stephanie Lheureux

Session I: Maintenance PARP inhibitors in ovarian cancer- Choosing wisely
Moderator: Dr. Julie Francis
8:30 Maintenance PARP inhibitors: treatment decisions, controversies, and challenges
Dr. Mansoor Raza Mirza
9:15 Selecting PARP inhibitors in the second line setting based on homologous recombination statu
Dr. Amit Oza
9:45 Real world management strategies of PARP inhibitor induced side effects
Dr. Kate Pulman
10:15 Panel discussion: effective utilization of PARP inhibitors in ovarian cancer
Dr. Mansoor Raza Mirza, Dr. Kate Pulman, Dr. Amit Oza
10:45 Health break with exhibtors

Session II: Introduction and integration of the newly developed Ovarian-Adnexal Reporting & Data System (ORADs) Moderator Dr. Laura White
11:00 Standardized reporting of Adnexal/Ovarian masses- an Ontario Health/CCO quality initiative
Dr. Sarah Ferguson
11:20 ORADs radiologic classification of ovarian neoplasms
Dr. Phyllis Glanc
11:40 Clinical significance of standardized ORADs reporting
Dr. Genevieve Bouchard
12:00 Panel discussion: Interpretation and integration of ORADs into clinical practice
Dr. Sarah Ferguson, Dr. Genevieve Bouchard, Dr. Phyllis Glanc
12:30 Lunch with exhibitors

Session III: Biomarkers-driven systemic and radiation therapy in endometrial cancer
1:30 Histologic, molecular and biomarker testing in endometrial cancer
Dr. Anjelica Hodgson
1:50 Question and answer period with audience
2:05 Biomarker driven therapy in endometrial cancer
Dr. Helen MacKay
2:30 Question and answer period with audience
2:45 Advances in radiation therapy in endometrial cancer
Dr. Kathy Han
3:15 Question and answer period with audience
3:30 Health break with exhibitors
3:45 Tumor board forum discussion- management guided by molecular profile in endometrial cancer
Dr. Anjelica Hodgson, Dr. Kathy Han & Dr. Helen Mackay
4:15 Concluding Remarks
Dr. Taymaa May, Dr. Stephanie Lheureux
4:30 End of day